Immuron Ltd.

Immuron Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD20.4 M
Shares Outstanding
163.22 M
Public Float
110 M

Profile

Address
62 Lygon Street
Carlton Victoria (VIC) 3053
Australia
Employees -
Website http://www.immuron.com
Updated 07/08/2019
Immuron Ltd. engages in the research and development of oral immunotherapy treatments using dairy-derived antibody products for humans. It operates through the following segments: Research and Development; HyperImmune Products; and Corporate. The Research and Development segment involves the research and development projects performed in Australia and Israel.

Financials

View All

Richard J. Berman
Non-Executive Director
Ravi Savarirayan
Non-Executive Director